Medication-info.com Search Menu

Ferriprox Tablet 1000 mg: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Boxed warning
Strength:
1000 mg, 500 mg
Drug class:
Active ingredient:
Similar drugs:

Patient information: uses, side effects, how to take - Ferriprox Tablet 1000 mg

What is the most important information I should know about FERRIPROX Tablets?

FERRIPROX Tablets can cause serious side effects, including a very low white blood cell count. One type of white blood cell that is important for fighting infections is called a neutrophil. If your neutrophil count is low (neutropenia), you may be at risk of developing a serious infection that can lead to death. Neutropenia is common with FERRIPROX Tablets and can become severe in some people. Severe neutropenia is known as agranulocytosis. If you develop agranulocytosis, you will be at risk of developing serious infections that can lead to death.

Your healthcare provider will do a blood test before you start FERRIPROX Tablets and regularly during treatment to check your neutrophil count. If you develop neutropenia, your healthcare provider should check your blood counts every day until your white blood cell count improves. Your healthcare provider may temporarily stop treatment with FERRIPROX Tablets if you develop neutropenia or infection.

Stop taking FERRIPROX Tablets and call your healthcare provider or get medical help right away if you develop any of these symptoms of infection:

  • fever
  • sore throat or mouth sores
  • flu-like symptoms
  • chills and severe shaking

It is important for you to have your white blood cell count checked within 24 hours of developing symptoms of an infection to see if you have severe neutropenia (agranulocytosis). Do not delay getting medical care if you are unable to reach your healthcare provider.

See “What are the possible side effects of FERRIPROX Tablets?” for more information about side effects.

What is FERRIPROX Tablets?

FERRIPROX Tablets is a prescription medicine used to treat iron overload from blood transfusions in adults and children 8 years of age and older with:

  • thalassemia syndromes.
  • sickle cell disease or other anemias.

It is not known if FERRIPROX Tablets is safe and effective to treat iron overload due to blood transfusions:

  • in people with myelodysplastic syndrome or Diamond Blackfan anemia
  • in children less than 8 years of age

Do not take FERRIPROX Tablets if you are allergic to deferiprone or any of the ingredients in FERRIPROX Tablets. See the end of this Medication Guide for a complete list of ingredients in FERRIPROX Tablets.

Before taking FERRIPROX Tablets, tell your healthcare provider about all of your medical conditions, including if you:

  • have liver problems
  • are pregnant or plan to become pregnant. FERRIPROX Tablets can harm your unborn baby. You should avoid becoming pregnant during treatment with FERRIPROX Tablets. Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with FERRIPROX Tablets.

Females who are able to become pregnant:

○ Your healthcare provider should do a pregnancy test before you start treatment with FERRIPROX Tablets.

○ You should use effective birth control during treatment with FERRIPROX Tablets and for at least 6 months after the last dose.

Males with female partners who are able to become pregnant:

○ You should use effective birth control during treatment with FERRIPROX Tablets and for at least 3 months after the last dose.

  • are breastfeeding or plan to breastfeed. It is not known if FERRIPROX Tablets passes into your breast milk. Do not breastfeed during treatment with FERRIPROX Tablets and for at least 2 weeks after the last dose.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements.

How should I take FERRIPROX Tablets?

  • Take FERRIPROX Tablets exactly as your healthcare provider tells you.
  • Your healthcare provider will prescribe FERRIPROX Tablets based on your body weight.
  • Your healthcare provider will check your body iron level during treatment with FERRIPROX Tablets and may change your dose if needed. Your healthcare provider may also change your dose of FERRIPROX Tablets if you have certain side effects. Do not change your dose of FERRIPROX Tablets unless your healthcare provider tells you to.
  • There are 2 types of FERRIPROX Tablets that are taken on different schedules. Be sure you are taking the correct tablet and ask your healthcare provider if unsure.

FERRIPROX Tablets

1,000 mg Twice-a-Day

2 times each day with food

FERRIPROX Tablets

1,000 mg

3 times each day

Take your first dose in the morning

and the second dose in the

evening, about 12 hours apart.

Take your first dose in the

morning, the second dose at mid

day, and the third dose in the

evening.

  • Taking FERRIPROX Tablets with meals may help reduce nausea.
  • If you must take a medicine to treat indigestion (antacid), or supplements that contain iron, aluminum, or zinc during treatment with FERRIPROX Tablets, allow at least 4 hours between taking FERRIPROX Tablets and these products.
  • If you take too much FERRIPROX Tablets, call your healthcare provider.
  • If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and then continue with your regular schedule. Do not try to catch-up or take 2 doses at the same time to make up for a missed dose.

What should I avoid during treatment with FERRIPROX Tablets?

  • Avoid drinking alcohol during treatment with FERRIPROX Tablets 1,000 mg (2 times a day). This may cause a faster release of the medicine.

What are the possible side effects of FERRIPROX Tablets?

FERRIPROX Tablets can cause serious side effects, including:

  • See “What is the most important information I should know about FERRIPROX Tablets?”
  • Increased liver enzyme levels in your blood. Your healthcare provider should do blood tests to check your liver function before you start and then monthly during treatment with FERRIPROX Tablets. Your healthcare provider may temporarily stop treatment with FERRIPROX Tablets if you develop increased liver enzyme levels and they continue to be increased.
  • Decreased levels of zinc in your blood. Your healthcare provider will do blood tests to check your zinc levels before you start and during treatment with FERRIPROX Tablets, and may prescribe a zinc supplement for you if your zinc levels are low.

The most common side effects of FERRIPROX Tablets in people with thalassemia include:

  • nausea
  • joint paint
  • vomiting
  • abnormal liver function tests
  • stomach-area (abdominal) pain
  • low white blood cells

The most common side effects of FERRIPROX Tablets in people with sickle cell disease or other anemias include:

  • fever
  • headache
  • sickle cell anemia with crisis
  • joint pain
  • low white blood cells
  • stomach-area (abdominal) pain
  • vomiting
  • back pain
  • mouth and throat pain
  • cough
  • bone pain
  • pain in arms or legs
  • abnormal liver function tests
  • common cold
  • nausea

FERRIPROX Tablets may cause a change in urine color to reddish-brown. This is not harmful and is expected during treatment with FERRIPROX Tablets.

These are not all of the possible side effects of FERRIPROX Tablets.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store FERRIPROX Tablets?

FERRIPROX Tablets

1,000 mg Twice-a-Day

2 times each day with food

FERRIPROX Tablets

1,000 mg

3 times each day

  • Store at room temperature between 68°F to 77°F (20°C to 25°C).
  • Store at room temperature between 68°F to 77°F (20°C to 25°C).
  • Store in the original bottle and tightly closed to protect from moisture.

Keep FERRIPROX Tablets and all medicines out of the reach of children.

General information about the safe and effective use of FERRIPROX Tablets.

Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use FERRIPROX Tablets for a condition for which it was not prescribed. Do not give FERRIPROX Tablets to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about FERRIPROX Tablets that is written for health professionals.

What are the ingredients in FERRIPROX Tablets?

FERRIPROX Tablets

1,000 mg Twice-a-Day

2 times each day with food

FERRIPROX Tablets

1,000 mg

3 times each day

Active ingredient: deferiprone

Inactive ingredients: Tablet core: hypromellose acetate succinate, magnesium oxide, colloidal silicon dioxide and magnesium stearate. Coating: triethyl citrate, talc, titanium dioxide, and methacrylic acid and ethyl acrylate copolymer.

Active ingredient: deferiprone

Inactive ingredients: Tablet core: methylcellulose, crospovidone, and magnesium stearate. Coating: hypromellose, hydroxypropyl cellulose, macrogol, and titanium dioxide.

Distributed by: Chiesi USA, Inc., Cary, NC 27518.

Manufactured by: Apotex Inc., Toronto, Ontario, Canada, M9L 1T9.

CTFD-033-0521-00-SPL-1

For more information, call 1-888-661-9260.

This Medication Guide has been approved by the U.S. Food and Drug Administration. Revised:01/2026

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: NDA 212269 · View the label on DailyMed

Revision date stated in the text: January 2026

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Ferriprox Tablet 1000 mg

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Boxed warning Yes – this drug has a boxed warning (also called a black box warning), the strongest warning of the FDA.
Drug class Iron Chelator
Active ingredient Deferiprone
Dosage form Tablet, Tablet, film coated
Route Oral
Marketing status listed in the FDA NDC Directory
Company (applicant) CHIESI
FDA approval NDA 212269New Drug Application (NDA) Approved May 19, 2020
Reference listed drug This is the reference listed drug (RLD) that generics are compared with.
Manufacturers 1 labelers list this drug on DailyMed
Packages (NDC)
Package
1000 mg – 50 in 1 blister pack NDC 10122-104-01
1000 mg – 50 in 1 bottle, plastic NDC 10122-104-05
1000 mg – 50 in 1 bottle, plastic NDC 10122-103-05
500 mg – 100 in 1 bottle, plastic NDC 10122-100-11
500 mg – 100 in 1 bottle, plastic NDC 10122-100-12

Source: FDA drug labeling via NLM DailyMed, data as of October 31, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.